On 14 July 2006, Millipore completed its acquisition of Serologicals; business divisions and subsidiaries known as Chemicon, Upstate and Linco will now operate within Millipore's bioscience division
Millipore will continue delivering all products currently available.
The goal of this combined company is to provide more innovative tools, services and application expertise that will improve productivity.
Millipore now offers:.
A broader range of reagents and kits for markets including protein identification, drug discovery, antibody purification, molecular biology, stem cell research, water purification and general filtration.
An increased number of applications and protocols that facilitate the development process.
Extended global expertise, leadership and presence.
Larger support and research development teams to deliver innovative products.
The employees of the new Millipore organisation will make every effort to ensure a smooth transition over time.
For your convenience, continue using the customer service telephone numbers, personnel and interactive web sites you have used in the past for Millipore, Chemicon, Upstate and Linco.
